Monroe Capital backs PE-backed ProPharma's acquisition of Xendo

Monroe Capital has increased its credit facility to ProPharma to support its acquisition of Xendo, a Dutch provider of compliance consulting, engineering & technical support, regulatory affairs, and pharmacovigilance services for the biopharmaceutical, medical device and healthcare industries. No financial terms were disclosed. ProPharma is backed by Linden Capital Partners.

North AmericaUSCreditBriefs